N/A•12d ago
BNTX Maintained by Canaccord Genuity -- Price Target Lowered to $136

BioNTech SE (BNTX) Analyst Rating Update On October 5, 2023, BioNTech (BNTX) received a rating update from Canaccord Genuity. Analyst John Newman has maintai
GuruFocus
Article
News
GuruFocus News
BNTX
Source: gurufocus.com


